These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23849326)

  • 41. Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant.
    Hooper WD; Dickinson RG; Dunstan PR; Pendlebury SC; Eadie MJ
    Clin Exp Neurol; 1987; 24():105-12. PubMed ID: 3268334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
    Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
    Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
    Miles MV; Tang PH; Ryan MA; Grim SA; Fakhoury TA; Strawsburg RH; DeGrauw TJ; Baumann RJ
    Ther Drug Monit; 2004 Jun; 26(3):300-4. PubMed ID: 15167632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans.
    Almeida L; Soares-da-Silva P
    Drugs R D; 2003; 4(5):269-84. PubMed ID: 12952496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
    Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
    Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of the efficacy and tolerability of oxcarbazepine oral suspension between infants and children with epilepsy: a retrospective chart review at a single medical center in Taiwan.
    Wei SH; Liu CC; Fan PC
    Paediatr Drugs; 2014 Feb; 16(1):83-9. PubMed ID: 24081427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of oxcarbazepine in the dog.
    Schicht S; Wigger D; Frey HH
    J Vet Pharmacol Ther; 1996 Feb; 19(1):27-31. PubMed ID: 8992022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
    Christensen J; Sabers A; Sidenius P
    Neurology; 2006 Oct; 67(8):1497-9. PubMed ID: 17060586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
    Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
    Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxcarbazepine therapy in very young children: a single-center clinical experience.
    Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
    Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study.
    de Jesus Antunes N; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre V; Takayanagui OM; Tozatto E; Lanchote VL
    Chirality; 2013 Dec; 25(12):897-903. PubMed ID: 24123382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy.
    Li RR; Sheng XY; Ma LY; Yao HX; Cai LX; Chen CY; Zhu SN; Zhou Y; Wu Y; Cui YM
    Ther Drug Monit; 2016 Jun; 38(3):365-70. PubMed ID: 26818624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment.
    Friis ML; Kristensen O; Boas J; Dalby M; Deth SH; Gram L; Mikkelsen M; Pedersen B; Sabers A; Worm-Petersen J
    Acta Neurol Scand; 1993 Mar; 87(3):224-7. PubMed ID: 8475694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oxcarbazepine in the treatment of epilepsy. A review and update].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy.
    Tolbert D; Cloyd J; Biton V; Bekersky I; Walzer M; Wesche D; Drummond R; Lee D
    Epilepsia; 2015 Jun; 56(6):915-23. PubMed ID: 25982590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemic mixture to dogs.
    Volosov A; Yagen B; Bialer M
    Epilepsia; 2000 Sep; 41(9):1107-11. PubMed ID: 10999549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.